nodes	percent_of_prediction	percent_of_DWPC	metapath
Pramipexole—DRD4—conduct disorder	0.602	0.684	CbGaD
Pramipexole—HTR2A—conduct disorder	0.278	0.316	CbGaD
Pramipexole—SLC22A2—Transmission across Chemical Synapses—COMT—conduct disorder	0.000164	0.00136	CbGpPWpGaD
Pramipexole—DRD3—Class A/1 (Rhodopsin-like receptors)—DRD4—conduct disorder	0.000164	0.00136	CbGpPWpGaD
Pramipexole—DRD5—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	0.000163	0.00136	CbGpPWpGaD
Pramipexole—SLC22A2—Transmission across Chemical Synapses—MAOA—conduct disorder	0.000163	0.00135	CbGpPWpGaD
Pramipexole—HTR1A—SIDS Susceptibility Pathways—HTR2A—conduct disorder	0.000162	0.00135	CbGpPWpGaD
Pramipexole—ADRA2C—GPCRs, Class A Rhodopsin-like—DRD4—conduct disorder	0.000161	0.00134	CbGpPWpGaD
Pramipexole—DRD2—G alpha (i) signalling events—DRD4—conduct disorder	0.000158	0.00131	CbGpPWpGaD
Pramipexole—HTR2B—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—conduct disorder	0.000155	0.00129	CbGpPWpGaD
Pramipexole—SLC22A1—Transmission across Chemical Synapses—COMT—conduct disorder	0.000153	0.00127	CbGpPWpGaD
Pramipexole—ADRA2A—GPCR ligand binding—CGA—conduct disorder	0.000152	0.00127	CbGpPWpGaD
Pramipexole—SLC22A1—Transmission across Chemical Synapses—MAOA—conduct disorder	0.000151	0.00126	CbGpPWpGaD
Pramipexole—ADRA2B—Class A/1 (Rhodopsin-like receptors)—DRD4—conduct disorder	0.000148	0.00123	CbGpPWpGaD
Pramipexole—HTR1D—GPCR downstream signaling—CGA—conduct disorder	0.000147	0.00122	CbGpPWpGaD
Pramipexole—DRD2—GPCRs, Class A Rhodopsin-like—DRD4—conduct disorder	0.000146	0.00122	CbGpPWpGaD
Pramipexole—HTR1D—GPCRs, Class A Rhodopsin-like—HTR2A—conduct disorder	0.000146	0.00121	CbGpPWpGaD
Pramipexole—HTR1D—GPCR ligand binding—DRD4—conduct disorder	0.000146	0.00121	CbGpPWpGaD
Pramipexole—HTR1B—GPCR downstream signaling—CGA—conduct disorder	0.000144	0.0012	CbGpPWpGaD
Pramipexole—HTR2A—GPCRs, Class A Rhodopsin-like—DRD4—conduct disorder	0.000144	0.0012	CbGpPWpGaD
Pramipexole—HTR1A—Class A/1 (Rhodopsin-like receptors)—DRD4—conduct disorder	0.000143	0.00119	CbGpPWpGaD
Pramipexole—HTR1B—GPCRs, Class A Rhodopsin-like—HTR2A—conduct disorder	0.000143	0.00119	CbGpPWpGaD
Pramipexole—HTR1B—GPCR ligand binding—DRD4—conduct disorder	0.000143	0.00119	CbGpPWpGaD
Pramipexole—HTR2C—Class A/1 (Rhodopsin-like receptors)—DRD4—conduct disorder	0.000142	0.00118	CbGpPWpGaD
Pramipexole—DRD4—GPCR downstream signaling—CGA—conduct disorder	0.000142	0.00118	CbGpPWpGaD
Pramipexole—ADRA2A—G alpha (i) signalling events—DRD4—conduct disorder	0.000141	0.00117	CbGpPWpGaD
Pramipexole—DRD4—GPCRs, Class A Rhodopsin-like—HTR2A—conduct disorder	0.00014	0.00117	CbGpPWpGaD
Pramipexole—SLC22A2—Transmembrane transport of small molecules—GABRA2—conduct disorder	0.00014	0.00117	CbGpPWpGaD
Pramipexole—HTR2C—G alpha (q) signalling events—HTR2A—conduct disorder	0.00014	0.00116	CbGpPWpGaD
Pramipexole—ADRA2C—Class A/1 (Rhodopsin-like receptors)—DRD4—conduct disorder	0.000138	0.00115	CbGpPWpGaD
Pramipexole—HTR2B—GPCR downstream signaling—CGA—conduct disorder	0.000135	0.00112	CbGpPWpGaD
Pramipexole—HTR2B—GPCRs, Class A Rhodopsin-like—HTR2A—conduct disorder	0.000134	0.00111	CbGpPWpGaD
Pramipexole—HTR2B—GPCR ligand binding—DRD4—conduct disorder	0.000134	0.00111	CbGpPWpGaD
Pramipexole—HTR1D—Signaling by GPCR—CGA—conduct disorder	0.000133	0.00111	CbGpPWpGaD
Pramipexole—ADRA2A—GPCRs, Class A Rhodopsin-like—DRD4—conduct disorder	0.000131	0.00109	CbGpPWpGaD
Pramipexole—HTR1B—Signaling by GPCR—CGA—conduct disorder	0.000131	0.00109	CbGpPWpGaD
Pramipexole—SLC22A1—Transmembrane transport of small molecules—GABRA2—conduct disorder	0.000131	0.00109	CbGpPWpGaD
Pramipexole—DRD4—Signaling by GPCR—CGA—conduct disorder	0.000129	0.00107	CbGpPWpGaD
Pramipexole—DRD1—GPCR downstream signaling—CGA—conduct disorder	0.000127	0.00106	CbGpPWpGaD
Pramipexole—DRD1—GPCRs, Class A Rhodopsin-like—HTR2A—conduct disorder	0.000126	0.00105	CbGpPWpGaD
Pramipexole—DRD1—GPCR ligand binding—DRD4—conduct disorder	0.000126	0.00105	CbGpPWpGaD
Pramipexole—DRD3—GPCR downstream signaling—CGA—conduct disorder	0.000126	0.00105	CbGpPWpGaD
Pramipexole—SLC22A2—Neuronal System—COMT—conduct disorder	0.000125	0.00104	CbGpPWpGaD
Pramipexole—DRD2—Class A/1 (Rhodopsin-like receptors)—DRD4—conduct disorder	0.000125	0.00104	CbGpPWpGaD
Pramipexole—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—conduct disorder	0.000125	0.00104	CbGpPWpGaD
Pramipexole—HTR1D—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	0.000125	0.00104	CbGpPWpGaD
Pramipexole—DRD3—GPCRs, Class A Rhodopsin-like—HTR2A—conduct disorder	0.000125	0.00104	CbGpPWpGaD
Pramipexole—DRD3—GPCR ligand binding—DRD4—conduct disorder	0.000125	0.00104	CbGpPWpGaD
Pramipexole—SLC22A2—Neuronal System—MAOA—conduct disorder	0.000125	0.00104	CbGpPWpGaD
Pramipexole—DRD5—GPCR ligand binding—HTR2A—conduct disorder	0.000124	0.00103	CbGpPWpGaD
Pramipexole—HTR2A—Class A/1 (Rhodopsin-like receptors)—DRD4—conduct disorder	0.000123	0.00103	CbGpPWpGaD
Pramipexole—HTR2B—Signaling by GPCR—CGA—conduct disorder	0.000123	0.00102	CbGpPWpGaD
Pramipexole—HTR1B—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	0.000122	0.00102	CbGpPWpGaD
Pramipexole—DRD4—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	0.00012	0.001	CbGpPWpGaD
Pramipexole—SLC22A1—Neuronal System—COMT—conduct disorder	0.000117	0.000972	CbGpPWpGaD
Pramipexole—SLC22A1—Neuronal System—MAOA—conduct disorder	0.000116	0.000966	CbGpPWpGaD
Pramipexole—DRD1—Signaling by GPCR—CGA—conduct disorder	0.000116	0.000963	CbGpPWpGaD
Pramipexole—HTR2B—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	0.000115	0.000955	CbGpPWpGaD
Pramipexole—DRD3—Signaling by GPCR—CGA—conduct disorder	0.000114	0.00095	CbGpPWpGaD
Pramipexole—ADRA2B—GPCR downstream signaling—CGA—conduct disorder	0.000114	0.000945	CbGpPWpGaD
Pramipexole—ADRA2B—GPCRs, Class A Rhodopsin-like—HTR2A—conduct disorder	0.000113	0.000936	CbGpPWpGaD
Pramipexole—ADRA2B—GPCR ligand binding—DRD4—conduct disorder	0.000113	0.000936	CbGpPWpGaD
Pramipexole—ADRA2A—Class A/1 (Rhodopsin-like receptors)—DRD4—conduct disorder	0.000112	0.000933	CbGpPWpGaD
Pramipexole—HTR1A—GPCR downstream signaling—CGA—conduct disorder	0.00011	0.000912	CbGpPWpGaD
Pramipexole—HTR2C—GPCR downstream signaling—CGA—conduct disorder	0.000109	0.000907	CbGpPWpGaD
Pramipexole—HTR1A—GPCRs, Class A Rhodopsin-like—HTR2A—conduct disorder	0.000109	0.000904	CbGpPWpGaD
Pramipexole—HTR1A—GPCR ligand binding—DRD4—conduct disorder	0.000109	0.000904	CbGpPWpGaD
Pramipexole—DRD1—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	0.000108	0.0009	CbGpPWpGaD
Pramipexole—HTR2C—GPCRs, Class A Rhodopsin-like—HTR2A—conduct disorder	0.000108	0.000899	CbGpPWpGaD
Pramipexole—HTR2C—GPCR ligand binding—DRD4—conduct disorder	0.000108	0.000899	CbGpPWpGaD
Pramipexole—DRD5—GPCR downstream signaling—DRD4—conduct disorder	0.000107	0.000894	CbGpPWpGaD
Pramipexole—DRD3—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	0.000107	0.000888	CbGpPWpGaD
Pramipexole—ADRA2C—GPCR downstream signaling—CGA—conduct disorder	0.000106	0.000882	CbGpPWpGaD
Pramipexole—ADRA2C—GPCRs, Class A Rhodopsin-like—HTR2A—conduct disorder	0.000105	0.000874	CbGpPWpGaD
Pramipexole—ADRA2C—GPCR ligand binding—DRD4—conduct disorder	0.000105	0.000874	CbGpPWpGaD
Pramipexole—ADRA2B—Signaling by GPCR—CGA—conduct disorder	0.000103	0.000858	CbGpPWpGaD
Pramipexole—DRD5—Signaling Pathways—CGA—conduct disorder	0.000103	0.000856	CbGpPWpGaD
Pramipexole—HTR1A—Signaling by GPCR—CGA—conduct disorder	9.95e-05	0.000828	CbGpPWpGaD
Pramipexole—HTR2C—Signaling by GPCR—CGA—conduct disorder	9.9e-05	0.000824	CbGpPWpGaD
Pramipexole—DRD5—Signaling by GPCR—DRD4—conduct disorder	9.76e-05	0.000812	CbGpPWpGaD
Pramipexole—ADRA2B—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	9.64e-05	0.000802	CbGpPWpGaD
Pramipexole—ADRA2C—Signaling by GPCR—CGA—conduct disorder	9.63e-05	0.000801	CbGpPWpGaD
Pramipexole—DRD2—GPCR downstream signaling—CGA—conduct disorder	9.62e-05	0.000801	CbGpPWpGaD
Pramipexole—DRD2—GPCRs, Class A Rhodopsin-like—HTR2A—conduct disorder	9.54e-05	0.000793	CbGpPWpGaD
Pramipexole—DRD2—GPCR ligand binding—DRD4—conduct disorder	9.54e-05	0.000793	CbGpPWpGaD
Pramipexole—HTR1D—GPCR ligand binding—HTR2A—conduct disorder	9.5e-05	0.00079	CbGpPWpGaD
Pramipexole—HTR2A—GPCR downstream signaling—CGA—conduct disorder	9.47e-05	0.000788	CbGpPWpGaD
Pramipexole—HTR2A—GPCR ligand binding—DRD4—conduct disorder	9.38e-05	0.000781	CbGpPWpGaD
Pramipexole—HTR1A—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	9.31e-05	0.000774	CbGpPWpGaD
Pramipexole—HTR1B—GPCR ligand binding—HTR2A—conduct disorder	9.3e-05	0.000774	CbGpPWpGaD
Pramipexole—HTR2C—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	9.26e-05	0.00077	CbGpPWpGaD
Pramipexole—DRD4—GPCR ligand binding—HTR2A—conduct disorder	9.15e-05	0.000762	CbGpPWpGaD
Pramipexole—DRD4—Circadian rythm related genes—EP300—conduct disorder	9.08e-05	0.000755	CbGpPWpGaD
Pramipexole—ADRA2C—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	9.01e-05	0.000749	CbGpPWpGaD
Pramipexole—DRD2—Signaling by GPCR—CGA—conduct disorder	8.74e-05	0.000727	CbGpPWpGaD
Pramipexole—HTR2B—GPCR ligand binding—HTR2A—conduct disorder	8.74e-05	0.000727	CbGpPWpGaD
Pramipexole—ADRA2A—GPCR downstream signaling—CGA—conduct disorder	8.61e-05	0.000717	CbGpPWpGaD
Pramipexole—HTR1A—SIDS Susceptibility Pathways—EP300—conduct disorder	8.61e-05	0.000716	CbGpPWpGaD
Pramipexole—HTR2A—Signaling by GPCR—CGA—conduct disorder	8.6e-05	0.000715	CbGpPWpGaD
Pramipexole—ADRA2A—GPCRs, Class A Rhodopsin-like—HTR2A—conduct disorder	8.54e-05	0.00071	CbGpPWpGaD
Pramipexole—ADRA2A—GPCR ligand binding—DRD4—conduct disorder	8.54e-05	0.00071	CbGpPWpGaD
Pramipexole—DRD5—Signaling Pathways—WASF1—conduct disorder	8.25e-05	0.000686	CbGpPWpGaD
Pramipexole—DRD1—GPCR ligand binding—HTR2A—conduct disorder	8.24e-05	0.000686	CbGpPWpGaD
Pramipexole—HTR1D—GPCR downstream signaling—DRD4—conduct disorder	8.23e-05	0.000685	CbGpPWpGaD
Pramipexole—DRD1—Circadian rythm related genes—EP300—conduct disorder	8.17e-05	0.00068	CbGpPWpGaD
Pramipexole—DRD2—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	8.17e-05	0.00068	CbGpPWpGaD
Pramipexole—DRD3—GPCR ligand binding—HTR2A—conduct disorder	8.13e-05	0.000677	CbGpPWpGaD
Pramipexole—DRD3—Circadian rythm related genes—EP300—conduct disorder	8.06e-05	0.000671	CbGpPWpGaD
Pramipexole—HTR1B—GPCR downstream signaling—DRD4—conduct disorder	8.06e-05	0.00067	CbGpPWpGaD
Pramipexole—HTR1D—Signaling Pathways—CGA—conduct disorder	7.88e-05	0.000656	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling by GPCR—CGA—conduct disorder	7.82e-05	0.000651	CbGpPWpGaD
Pramipexole—HTR1B—Signaling Pathways—CGA—conduct disorder	7.72e-05	0.000642	CbGpPWpGaD
Pramipexole—DRD4—Signaling Pathways—CGA—conduct disorder	7.6e-05	0.000632	CbGpPWpGaD
Pramipexole—HTR2B—GPCR downstream signaling—DRD4—conduct disorder	7.57e-05	0.00063	CbGpPWpGaD
Pramipexole—HTR1D—Signaling by GPCR—DRD4—conduct disorder	7.47e-05	0.000622	CbGpPWpGaD
Pramipexole—HTR2A—SIDS Susceptibility Pathways—EP300—conduct disorder	7.44e-05	0.000619	CbGpPWpGaD
Pramipexole—ADRA2B—GPCR ligand binding—HTR2A—conduct disorder	7.34e-05	0.000611	CbGpPWpGaD
Pramipexole—HTR1B—Signaling by GPCR—DRD4—conduct disorder	7.32e-05	0.000609	CbGpPWpGaD
Pramipexole—ADRA2A—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	7.31e-05	0.000609	CbGpPWpGaD
Pramipexole—HTR2B—Signaling Pathways—CGA—conduct disorder	7.25e-05	0.000603	CbGpPWpGaD
Pramipexole—DRD1—GPCR downstream signaling—DRD4—conduct disorder	7.14e-05	0.000594	CbGpPWpGaD
Pramipexole—HTR1A—GPCR ligand binding—HTR2A—conduct disorder	7.09e-05	0.00059	CbGpPWpGaD
Pramipexole—HTR2C—GPCR ligand binding—HTR2A—conduct disorder	7.05e-05	0.000587	CbGpPWpGaD
Pramipexole—DRD3—GPCR downstream signaling—DRD4—conduct disorder	7.04e-05	0.000586	CbGpPWpGaD
Pramipexole—DRD5—GPCR downstream signaling—HTR2A—conduct disorder	7.01e-05	0.000583	CbGpPWpGaD
Pramipexole—SLC22A2—Metabolism—CGA—conduct disorder	7e-05	0.000582	CbGpPWpGaD
Pramipexole—HTR2B—Signaling by GPCR—DRD4—conduct disorder	6.87e-05	0.000572	CbGpPWpGaD
Pramipexole—ADRA2C—GPCR ligand binding—HTR2A—conduct disorder	6.86e-05	0.000571	CbGpPWpGaD
Pramipexole—DRD1—Signaling Pathways—CGA—conduct disorder	6.84e-05	0.000569	CbGpPWpGaD
Pramipexole—ADRA2C—Metabolism—CGA—conduct disorder	6.8e-05	0.000566	CbGpPWpGaD
Pramipexole—DRD3—Signaling Pathways—CGA—conduct disorder	6.75e-05	0.000561	CbGpPWpGaD
Pramipexole—SLC22A1—Metabolism—CGA—conduct disorder	6.52e-05	0.000542	CbGpPWpGaD
Pramipexole—DRD1—Signaling by GPCR—DRD4—conduct disorder	6.48e-05	0.000539	CbGpPWpGaD
Pramipexole—DRD3—Signaling by GPCR—DRD4—conduct disorder	6.4e-05	0.000532	CbGpPWpGaD
Pramipexole—DRD5—Signaling by GPCR—HTR2A—conduct disorder	6.37e-05	0.00053	CbGpPWpGaD
Pramipexole—ADRA2B—GPCR downstream signaling—DRD4—conduct disorder	6.36e-05	0.000529	CbGpPWpGaD
Pramipexole—HTR1D—Signaling Pathways—WASF1—conduct disorder	6.32e-05	0.000526	CbGpPWpGaD
Pramipexole—DRD2—GPCR ligand binding—HTR2A—conduct disorder	6.22e-05	0.000518	CbGpPWpGaD
Pramipexole—HTR1B—Signaling Pathways—WASF1—conduct disorder	6.19e-05	0.000515	CbGpPWpGaD
Pramipexole—DRD2—Circadian rythm related genes—EP300—conduct disorder	6.17e-05	0.000513	CbGpPWpGaD
Pramipexole—HTR1A—GPCR downstream signaling—DRD4—conduct disorder	6.14e-05	0.000511	CbGpPWpGaD
Pramipexole—HTR2C—GPCR downstream signaling—DRD4—conduct disorder	6.11e-05	0.000508	CbGpPWpGaD
Pramipexole—ADRA2B—Signaling Pathways—CGA—conduct disorder	6.09e-05	0.000507	CbGpPWpGaD
Pramipexole—DRD4—Signaling Pathways—WASF1—conduct disorder	6.09e-05	0.000506	CbGpPWpGaD
Pramipexole—ADRA2C—GPCR downstream signaling—DRD4—conduct disorder	5.94e-05	0.000494	CbGpPWpGaD
Pramipexole—HTR1A—Signaling Pathways—CGA—conduct disorder	5.88e-05	0.000489	CbGpPWpGaD
Pramipexole—HTR2C—Signaling Pathways—CGA—conduct disorder	5.85e-05	0.000487	CbGpPWpGaD
Pramipexole—HTR2B—Signaling Pathways—WASF1—conduct disorder	5.81e-05	0.000483	CbGpPWpGaD
Pramipexole—ADRA2B—Signaling by GPCR—DRD4—conduct disorder	5.77e-05	0.00048	CbGpPWpGaD
Pramipexole—DRD5—Signaling Pathways—DRD4—conduct disorder	5.76e-05	0.000479	CbGpPWpGaD
Pramipexole—ADRA2C—Signaling Pathways—CGA—conduct disorder	5.69e-05	0.000473	CbGpPWpGaD
Pramipexole—HTR1A—Signaling by GPCR—DRD4—conduct disorder	5.57e-05	0.000464	CbGpPWpGaD
Pramipexole—ADRA2A—GPCR ligand binding—HTR2A—conduct disorder	5.57e-05	0.000463	CbGpPWpGaD
Pramipexole—HTR2C—Signaling by GPCR—DRD4—conduct disorder	5.55e-05	0.000461	CbGpPWpGaD
Pramipexole—ADRA2A—Metabolism—CGA—conduct disorder	5.53e-05	0.00046	CbGpPWpGaD
Pramipexole—DRD1—Signaling Pathways—WASF1—conduct disorder	5.48e-05	0.000456	CbGpPWpGaD
Pramipexole—DRD3—Signaling Pathways—WASF1—conduct disorder	5.41e-05	0.00045	CbGpPWpGaD
Pramipexole—ADRA2C—Signaling by GPCR—DRD4—conduct disorder	5.39e-05	0.000449	CbGpPWpGaD
Pramipexole—DRD2—GPCR downstream signaling—DRD4—conduct disorder	5.39e-05	0.000448	CbGpPWpGaD
Pramipexole—HTR1D—GPCR downstream signaling—HTR2A—conduct disorder	5.37e-05	0.000447	CbGpPWpGaD
Pramipexole—HTR2A—GPCR downstream signaling—DRD4—conduct disorder	5.3e-05	0.000441	CbGpPWpGaD
Pramipexole—HTR1B—GPCR downstream signaling—HTR2A—conduct disorder	5.26e-05	0.000437	CbGpPWpGaD
Pramipexole—DRD4—GPCR downstream signaling—HTR2A—conduct disorder	5.17e-05	0.00043	CbGpPWpGaD
Pramipexole—DRD2—Signaling Pathways—CGA—conduct disorder	5.16e-05	0.000429	CbGpPWpGaD
Pramipexole—HTR2A—Signaling Pathways—CGA—conduct disorder	5.08e-05	0.000423	CbGpPWpGaD
Pramipexole—HTR2B—GPCR downstream signaling—HTR2A—conduct disorder	4.94e-05	0.000411	CbGpPWpGaD
Pramipexole—DRD2—Signaling by GPCR—DRD4—conduct disorder	4.89e-05	0.000407	CbGpPWpGaD
Pramipexole—ADRA2B—Signaling Pathways—WASF1—conduct disorder	4.88e-05	0.000406	CbGpPWpGaD
Pramipexole—HTR1D—Signaling by GPCR—HTR2A—conduct disorder	4.88e-05	0.000406	CbGpPWpGaD
Pramipexole—ADRA2A—GPCR downstream signaling—DRD4—conduct disorder	4.82e-05	0.000401	CbGpPWpGaD
Pramipexole—HTR2A—Signaling by GPCR—DRD4—conduct disorder	4.82e-05	0.000401	CbGpPWpGaD
Pramipexole—HTR1B—Signaling by GPCR—HTR2A—conduct disorder	4.77e-05	0.000397	CbGpPWpGaD
Pramipexole—HTR1A—Signaling Pathways—WASF1—conduct disorder	4.71e-05	0.000392	CbGpPWpGaD
Pramipexole—DRD4—Signaling by GPCR—HTR2A—conduct disorder	4.7e-05	0.000391	CbGpPWpGaD
Pramipexole—HTR2C—Signaling Pathways—WASF1—conduct disorder	4.69e-05	0.00039	CbGpPWpGaD
Pramipexole—DRD1—GPCR downstream signaling—HTR2A—conduct disorder	4.66e-05	0.000387	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling Pathways—CGA—conduct disorder	4.62e-05	0.000384	CbGpPWpGaD
Pramipexole—DRD3—GPCR downstream signaling—HTR2A—conduct disorder	4.6e-05	0.000382	CbGpPWpGaD
Pramipexole—ADRA2C—Signaling Pathways—WASF1—conduct disorder	4.56e-05	0.000379	CbGpPWpGaD
Pramipexole—HTR2B—Signaling by GPCR—HTR2A—conduct disorder	4.48e-05	0.000373	CbGpPWpGaD
Pramipexole—HTR1D—Signaling Pathways—DRD4—conduct disorder	4.41e-05	0.000367	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling by GPCR—DRD4—conduct disorder	4.38e-05	0.000364	CbGpPWpGaD
Pramipexole—HTR1B—Signaling Pathways—DRD4—conduct disorder	4.32e-05	0.00036	CbGpPWpGaD
Pramipexole—DRD1—Signaling by GPCR—HTR2A—conduct disorder	4.23e-05	0.000352	CbGpPWpGaD
Pramipexole—DRD3—Signaling by GPCR—HTR2A—conduct disorder	4.17e-05	0.000347	CbGpPWpGaD
Pramipexole—ADRA2B—GPCR downstream signaling—HTR2A—conduct disorder	4.15e-05	0.000345	CbGpPWpGaD
Pramipexole—DRD2—Signaling Pathways—WASF1—conduct disorder	4.14e-05	0.000344	CbGpPWpGaD
Pramipexole—HTR2A—Signaling Pathways—WASF1—conduct disorder	4.07e-05	0.000339	CbGpPWpGaD
Pramipexole—HTR2B—Signaling Pathways—DRD4—conduct disorder	4.06e-05	0.000338	CbGpPWpGaD
Pramipexole—HTR1A—GPCR downstream signaling—HTR2A—conduct disorder	4e-05	0.000333	CbGpPWpGaD
Pramipexole—HTR2C—GPCR downstream signaling—HTR2A—conduct disorder	3.98e-05	0.000331	CbGpPWpGaD
Pramipexole—ADRA2C—GPCR downstream signaling—HTR2A—conduct disorder	3.88e-05	0.000322	CbGpPWpGaD
Pramipexole—DRD1—Signaling Pathways—DRD4—conduct disorder	3.83e-05	0.000319	CbGpPWpGaD
Pramipexole—DRD3—Signaling Pathways—DRD4—conduct disorder	3.78e-05	0.000314	CbGpPWpGaD
Pramipexole—ADRA2B—Signaling by GPCR—HTR2A—conduct disorder	3.77e-05	0.000313	CbGpPWpGaD
Pramipexole—DRD5—Signaling Pathways—HTR2A—conduct disorder	3.76e-05	0.000313	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling Pathways—WASF1—conduct disorder	3.7e-05	0.000308	CbGpPWpGaD
Pramipexole—HTR1A—Signaling by GPCR—HTR2A—conduct disorder	3.64e-05	0.000303	CbGpPWpGaD
Pramipexole—HTR2C—Signaling by GPCR—HTR2A—conduct disorder	3.62e-05	0.000301	CbGpPWpGaD
Pramipexole—ADRA2C—Signaling by GPCR—HTR2A—conduct disorder	3.52e-05	0.000293	CbGpPWpGaD
Pramipexole—DRD2—GPCR downstream signaling—HTR2A—conduct disorder	3.52e-05	0.000293	CbGpPWpGaD
Pramipexole—ADRA2B—Hemostasis—EP300—conduct disorder	3.48e-05	0.000289	CbGpPWpGaD
Pramipexole—ADRA2B—Signaling Pathways—DRD4—conduct disorder	3.41e-05	0.000284	CbGpPWpGaD
Pramipexole—HTR1A—Signaling Pathways—DRD4—conduct disorder	3.29e-05	0.000274	CbGpPWpGaD
Pramipexole—HTR2C—Signaling Pathways—DRD4—conduct disorder	3.28e-05	0.000273	CbGpPWpGaD
Pramipexole—ADRA2C—Hemostasis—EP300—conduct disorder	3.25e-05	0.00027	CbGpPWpGaD
Pramipexole—DRD2—Signaling by GPCR—HTR2A—conduct disorder	3.19e-05	0.000266	CbGpPWpGaD
Pramipexole—ADRA2C—Signaling Pathways—DRD4—conduct disorder	3.19e-05	0.000265	CbGpPWpGaD
Pramipexole—SLC22A2—Metabolism—COMT—conduct disorder	3.16e-05	0.000263	CbGpPWpGaD
Pramipexole—ADRA2A—GPCR downstream signaling—HTR2A—conduct disorder	3.15e-05	0.000262	CbGpPWpGaD
Pramipexole—SLC22A2—Metabolism—MAOA—conduct disorder	3.14e-05	0.000261	CbGpPWpGaD
Pramipexole—ADRA2C—Metabolism—COMT—conduct disorder	3.07e-05	0.000256	CbGpPWpGaD
Pramipexole—ADRA2C—Metabolism—MAOA—conduct disorder	3.05e-05	0.000254	CbGpPWpGaD
Pramipexole—SLC22A1—Metabolism—COMT—conduct disorder	2.94e-05	0.000245	CbGpPWpGaD
Pramipexole—SLC22A1—Metabolism—MAOA—conduct disorder	2.92e-05	0.000243	CbGpPWpGaD
Pramipexole—DRD2—Signaling Pathways—DRD4—conduct disorder	2.89e-05	0.000241	CbGpPWpGaD
Pramipexole—HTR1D—Signaling Pathways—HTR2A—conduct disorder	2.88e-05	0.00024	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling by GPCR—HTR2A—conduct disorder	2.86e-05	0.000238	CbGpPWpGaD
Pramipexole—HTR2A—Signaling Pathways—DRD4—conduct disorder	2.84e-05	0.000237	CbGpPWpGaD
Pramipexole—HTR1B—Signaling Pathways—HTR2A—conduct disorder	2.82e-05	0.000235	CbGpPWpGaD
Pramipexole—DRD4—Signaling Pathways—HTR2A—conduct disorder	2.78e-05	0.000231	CbGpPWpGaD
Pramipexole—HTR2B—Signaling Pathways—HTR2A—conduct disorder	2.65e-05	0.00022	CbGpPWpGaD
Pramipexole—ADRA2A—Hemostasis—EP300—conduct disorder	2.64e-05	0.00022	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling Pathways—DRD4—conduct disorder	2.59e-05	0.000215	CbGpPWpGaD
Pramipexole—DRD1—Signaling Pathways—HTR2A—conduct disorder	2.5e-05	0.000208	CbGpPWpGaD
Pramipexole—ADRA2A—Metabolism—COMT—conduct disorder	2.49e-05	0.000208	CbGpPWpGaD
Pramipexole—ADRA2A—Metabolism—MAOA—conduct disorder	2.48e-05	0.000206	CbGpPWpGaD
Pramipexole—DRD3—Signaling Pathways—HTR2A—conduct disorder	2.47e-05	0.000205	CbGpPWpGaD
Pramipexole—ADRA2B—Signaling Pathways—HTR2A—conduct disorder	2.23e-05	0.000185	CbGpPWpGaD
Pramipexole—HTR1A—Signaling Pathways—HTR2A—conduct disorder	2.15e-05	0.000179	CbGpPWpGaD
Pramipexole—HTR2C—Signaling Pathways—HTR2A—conduct disorder	2.14e-05	0.000178	CbGpPWpGaD
Pramipexole—ADRA2C—Signaling Pathways—HTR2A—conduct disorder	2.08e-05	0.000173	CbGpPWpGaD
Pramipexole—DRD5—Signaling Pathways—EP300—conduct disorder	1.99e-05	0.000166	CbGpPWpGaD
Pramipexole—DRD2—Signaling Pathways—HTR2A—conduct disorder	1.89e-05	0.000157	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling Pathways—HTR2A—conduct disorder	1.69e-05	0.00014	CbGpPWpGaD
Pramipexole—HTR1D—Signaling Pathways—EP300—conduct disorder	1.53e-05	0.000127	CbGpPWpGaD
Pramipexole—HTR1B—Signaling Pathways—EP300—conduct disorder	1.49e-05	0.000124	CbGpPWpGaD
Pramipexole—DRD4—Signaling Pathways—EP300—conduct disorder	1.47e-05	0.000122	CbGpPWpGaD
Pramipexole—HTR2B—Signaling Pathways—EP300—conduct disorder	1.4e-05	0.000117	CbGpPWpGaD
Pramipexole—SLC22A2—Metabolism—EP300—conduct disorder	1.35e-05	0.000113	CbGpPWpGaD
Pramipexole—DRD1—Signaling Pathways—EP300—conduct disorder	1.32e-05	0.00011	CbGpPWpGaD
Pramipexole—ADRA2C—Metabolism—EP300—conduct disorder	1.32e-05	0.00011	CbGpPWpGaD
Pramipexole—DRD3—Signaling Pathways—EP300—conduct disorder	1.31e-05	0.000109	CbGpPWpGaD
Pramipexole—SLC22A1—Metabolism—EP300—conduct disorder	1.26e-05	0.000105	CbGpPWpGaD
Pramipexole—ADRA2B—Signaling Pathways—EP300—conduct disorder	1.18e-05	9.81e-05	CbGpPWpGaD
Pramipexole—HTR1A—Signaling Pathways—EP300—conduct disorder	1.14e-05	9.47e-05	CbGpPWpGaD
Pramipexole—HTR2C—Signaling Pathways—EP300—conduct disorder	1.13e-05	9.42e-05	CbGpPWpGaD
Pramipexole—ADRA2C—Signaling Pathways—EP300—conduct disorder	1.1e-05	9.16e-05	CbGpPWpGaD
Pramipexole—ADRA2A—Metabolism—EP300—conduct disorder	1.07e-05	8.9e-05	CbGpPWpGaD
Pramipexole—DRD2—Signaling Pathways—EP300—conduct disorder	9.99e-06	8.31e-05	CbGpPWpGaD
Pramipexole—HTR2A—Signaling Pathways—EP300—conduct disorder	9.83e-06	8.18e-05	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling Pathways—EP300—conduct disorder	8.95e-06	7.44e-05	CbGpPWpGaD
